The neutropenia induced by the thalidomide analogue CC-4047 in patients with multiple myeloma is associated with an increased percentage of neutrophils bearing CD64D. McCarthy, K A Brown, Marion G. Macey et al.|International Immunopharmacology|2006Cited by 13